🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

Recruitingn/aAges 12 Years - anyAllAlnylam Pharmaceuticals
NCT04883905 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Documented diagnosis of AHP, per physician's determination Exclusion Criteria: * Currently enrolled in a clinical trial for any investigational agent
💊

What it tests

  • Not listed
📍

Where

30 sites
Clinical Trial Site
Birmingham, United States
Clinical Trial Site
Gilbert, United States
Clinical Trial Site
San Francisco, United States
Clinical Trial Site
Baltimore, United States
Clinical Trial Site
Boston, United States
Clinical Trial Site
Minneapolis, United States
Clinical Trial Site
New York, United States
Clinical Trial Site
Winston-Salem, United States

…and 22 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy